Novel haemodialysis (HD) treatment employing molecular hydrogen (H 2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study
Hirofumi Nakano, Hiromi Hamada, Hodaka Suzuki, Kazumasa Tsunoda, Mariko Miyazaki, Masaaki Nakayama, Naoyuki Osaka, Noritomo Itami, Ryo Yamamoto, Ryoichi Nakazawa, Sadayoshi Ito, Shigeru Kabayama, Yukio Maruyama
Abstract:
Recent studies have revealed unique biological characteristics of molecular hydrogen (H2) as an anti-inflammatory agent. We developed a novel haemodialysis (E-HD) system delivering an H2 (30-80 ppb)-enriched dialysis solution by water electrolysis, and conducted a non-randomized, non-blinded, prospective observational study exploring its clinical impact. Prevalent chronic HD patients were allocated to either the E-HD (n = 161) group or the conventional HD (C-HD: n = 148) group, and received the respective HD treatments during the study. The primary endpoint was a composite of all-cause mortality and development of non-lethal cardio-cerebrovascular events (cardiac disease, apoplexy, and leg amputation due to peripheral artery disease). During the 3.28-year mean observation period, there were no differences in dialysis parameters between the two groups; however, post-dialysis hypertension was ameliorated with significant reductions in antihypertensive agents in the E-HD patients. There were 91 events (50 in the C-HD group and 41 in the E-HD group). Multivariate analysis of the Cox proportional hazards model revealed E-HD as an independent significant factor for the primary endpoint (hazard ratio 0.59; [95% confidence interval: 0.38-0.92]) after adjusting for confounding factors (age, cardiovascular disease history, serum albumin, and C-reactive protein). HD applying an H2-dissolved HD solution could improve the prognosis of chronic HD patients.
Publish Year |
2018 |
Country |
Japan |
Rank |
Positive |
Journal |
Nature Scientific Reports |
Primary Topic |
Kidney |
Secondary Topic | Haemodialysis |
Model |
Human |
Tertiary Topic | Life Expectancy |
Vehicle |
Solution (Dissolved) |
pH |
Alkaline |
Application |
Injection |
Comparison |
|
Complement |
|
Molecular hydrogen: prospective treatment strategy of kidney damage after cardiac surgery
2023 - Kidney - Surgery/Transplantation
Cardiac surgery-associated acute kidney injury (CS-AKI) is a common postoperative complication, mostly due increasing oxidative stress. Recently, molecular hydrogen (H2 gas), has also been applied to cardiac surgery due to its ability to reduce ...
Effect of water diuresis with hydrogen saturation on the course of acute kidney damage during the ...
2022 - Kidney - Acute Kidney Injury
Molecular hydrogen has the ability to penetrate cells, easily reach mitochondria, overcome body barriers, penetrate areas of ischemia, edema and inflammation, improve energy supply by supplying additional electrons and have antioxidant and ...
Inhalation of 4% and 67% hydrogen ameliorates oxidative stress, inflammation, apoptosis, and ...
2023 - Kidney - Acute Kidney Injury
Acute kidney injury (AKI) is the major complication of rhabdomyolysis (RM) clinically, which is usually mimicked by glycerol injection in basic research. Oxidative stress, inflammatory response and apoptosis are recognized to play important roles in ...
Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed ...
2003 - Kidney - Haemodialysis
Background: Increased oxidative stress in end-stage renal disease (ESRD) patients may oxidize macromolecules and consequently lead to cardiovascular events during chronic hemodialysis. Electrolyzed reduced water (ERW) with reactive oxygen species ...
Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal ...
2006 - Kidney - Haemodialysis
Chronic hemodialysis (HD) patients increase erythrocyte susceptibility to hemolysis and impair cell survival. We explored whether electrolyte-reduced water (ERW) could palliate HD-evoked erythrocyte impairment and anemia. Forty-three patients ...
Less-oxidative hemodialysis solution rendered by cathode-side application of electrolyzed water
2007 - Kidney - Haemodialysis
Electrolyzed water (EW) generated on the cathode side reportedly displays anti-oxidative properties, and application of EW to hemodialysis (HD) systems supposedly suppresses oxidative markers in patients on HD. However, most of the chemical ...